News

The Brain Song represents a breakthrough in cognitive wellness technologies for 2025, utilizing scientifically-backed audio ...
Two recent studies of nursing homes and home-based care emphasize how communication breakdowns between care team members can undermine patient safety. A Swedish study of 112 assistant nurses in ...
Concern about the cost of GLP-1s remains high, and a new study suggests it's not uncommon for patients to overpay for these ...
The GIST Study offers new insights into first-principles calculations of hadron structure by Zhang Nannan, Chinese Academy of Sciences edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
Ibrahim Aldoss, MD, discusses the potential of AZD0486 for treating relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and outlines the SYRUS study objectives.
Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research ...
AbbVie beat out a competitor's migraine-fighting drug in terms of dose tolerability in a head-to-head study. The North Chicago-based drugmaker said its Phase 3 study of atogepant (Qulipta) in a ...
The growth of the complicated urinary tract infections market is expected to be mainly driven by the entry of new therapies such as Tebipenem Pivoxil Hydrobromide (SPR994), ZAYNICH ...
Test Boost Max enters 2025 as a leading plant-based testosterone supplement, offering men a science-backed, non-synthetic ...
New guidelines from the American College of Cardiology and American Heart Association update best practices for managing peripheral artery disease (PAD). The comprehensive clinical guidelines synopsis ...
Otsuka tops Vera Therapeutics in kidney disease study showdown Both companies are racing to develop new treatments for IgA nephropathy Adobe By Adam Feuerstein June 6, 2025 Senior Writer, Biotech ...